Chest Radiation for Advanced Lung Cancer at High Risk of Symptoms
Part of Cancer, Lungs & breathing clinical trials.
This study tests whether giving radiation to tumors in the chest soon after starting systemic therapy can help prevent symptoms like pain, trouble breathing, or bleeding. It is for people with advanced non-small cell lung cancer that does not have certain gene changes and has high-risk tumors in the chest.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-small cell lung cancer (NSCLC) that has spread (stage IV) or has come back after initial treatment.
- Your tumor does not have certain gene changes (EGFR, ALK, or ROS1 mutations).
- You have a tumor in your chest area (lung or lymph nodes) that is at least 2 to 5 cm, or is touching important structures like your windpipe, esophagus, spine, heart, or major blood vessels.
- You have not had radiation to your chest before.
- You started a new systemic therapy (chemotherapy, immunotherapy, etc.) for stage IV disease within the last 6 months (or are about to start it).
- You are able to take care of yourself and are up and about more than half the day.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new approach for advanced non-small cell lung cancer that cannot be surgically removed. It combines a focused, high-dose radiation treatment to the tumor core followed by standard chemotherapy and radiation together. This may help fight the cancer more effectively.
This trial tests whether aiming radiation at the main lung tumor can help people with advanced lung cancer that has spread to many places. It is for people who have not had much treatment yet or whose cancer is currently stable.
This trial is for people with advanced non-small cell lung cancer whose tumors responded well to initial chemo-immunotherapy. Instead of giving full chest radiation, doctors will only target the main tumor to see if it can prevent regrowth with fewer side effects.
This trial tests whether a special type of focused radiation therapy can effectively treat advanced non-small cell lung cancer (the most common type) as an upfront treatment. It may help patients avoid or delay chemotherapy while controlling their cancer.
This early study tests whether a specific kind of radiation can be safely given to people with newly diagnosed metastatic lung cancer when cure isn’t possible. It’s meant to see how well the treatment can be delivered and how it affects outcomes in a specific genetic group of tumors.
This trial tests whether giving radiation to the main lung tumor, along with standard therapy (like chemo or immunotherapy), helps people with newly diagnosed stage IV lung cancer live longer. It is for people whose cancer does not have certain gene changes (EGFR, ALK, ROS1) and who have tumors in only a few other organs.
Hear when a new Stage 4 NSCLC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.